2/19
08:03 am
uncy
Unicycive Therapeutics (NASDAQ:UNCY) is now covered by analysts at Westpark Capital. They set a "buy" rating on the stock.
Low
Report
Unicycive Therapeutics (NASDAQ:UNCY) is now covered by analysts at Westpark Capital. They set a "buy" rating on the stock.
2/4
07:05 am
uncy
Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit
Medium
Report
Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit
1/29
04:16 pm
uncy
Unicycive: 'Buy' Rating On NDA Resubmission OLC And Potential Best-In-Class Profile [Seeking Alpha]
High
Report
Unicycive: 'Buy' Rating On NDA Resubmission OLC And Potential Best-In-Class Profile [Seeking Alpha]
1/29
09:15 am
uncy
UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Medium
Report
UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
1/29
07:31 am
uncy
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission [Yahoo! Finance]
1/29
07:05 am
uncy
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Medium
Report
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
12/30
08:42 am
uncy
Unicycive Therapeutics (NASDAQ:UNCY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Unicycive Therapeutics (NASDAQ:UNCY) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/29
04:27 pm
uncy
Unicycive resubmits NDA for hyperphosphatemia asset [Seeking Alpha]
Medium
Report
Unicycive resubmits NDA for hyperphosphatemia asset [Seeking Alpha]
12/29
07:47 am
uncy
Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth [Yahoo! Finance]
Medium
Report
Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth [Yahoo! Finance]
12/29
07:21 am
uncy
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) [Yahoo! Finance]
12/29
07:05 am
uncy
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
Medium
Report
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
12/10
11:42 am
uncy
2025 Forbes Healthcare Summit | How To Make Medicine Personal [Forbes]
Low
Report
2025 Forbes Healthcare Summit | How To Make Medicine Personal [Forbes]